TW200714716A - Method - Google Patents

Method

Info

Publication number
TW200714716A
TW200714716A TW094143956A TW94143956A TW200714716A TW 200714716 A TW200714716 A TW 200714716A TW 094143956 A TW094143956 A TW 094143956A TW 94143956 A TW94143956 A TW 94143956A TW 200714716 A TW200714716 A TW 200714716A
Authority
TW
Taiwan
Prior art keywords
mutations
dna
receptor
sample
bio
Prior art date
Application number
TW094143956A
Other languages
English (en)
Inventor
Kazuto Nishio
Hideharu Kimura
Kazuo Kasahara
Original Assignee
Astrazeneca Uk Ltd
Nat Cancer Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd, Nat Cancer Ct filed Critical Astrazeneca Uk Ltd
Publication of TW200714716A publication Critical patent/TW200714716A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
TW094143956A 2005-10-05 2005-12-13 Method TW200714716A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2005003823 2005-10-05
PCT/GB2005/004036 WO2007039705A1 (en) 2005-10-05 2005-10-20 Method to predict or monitor the response of a patient to an erbb receptor drug

Publications (1)

Publication Number Publication Date
TW200714716A true TW200714716A (en) 2007-04-16

Family

ID=36114238

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094143956A TW200714716A (en) 2005-10-05 2005-12-13 Method

Country Status (14)

Country Link
US (1) US20080286785A1 (zh)
EP (1) EP1931798A1 (zh)
JP (1) JP2009511008A (zh)
KR (1) KR20080028857A (zh)
CN (1) CN101351563A (zh)
AU (1) AU2005337051A1 (zh)
BR (1) BRPI0520530A2 (zh)
CA (1) CA2624613A1 (zh)
IL (1) IL189705A0 (zh)
NO (1) NO20081198L (zh)
NZ (1) NZ566387A (zh)
TW (1) TW200714716A (zh)
WO (1) WO2007039705A1 (zh)
ZA (1) ZA200802854B (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102886045A (zh) 2005-02-03 2013-01-23 综合医院公司 治疗吉非替尼耐药性癌症的方法
KR101354828B1 (ko) 2005-11-04 2014-02-18 와이어쓰 엘엘씨 ｍＴＯＲ 저해자, 헤르셉틴, 및/또는 ＨＫＩ-272의항신생물성 조합
SI2129396T1 (sl) 2007-02-16 2013-12-31 Merrimack Pharmaceuticals, Inc. Protitelesa proti ErbB3 in njihove uporabe
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
EP3135285B1 (en) 2008-06-17 2018-08-15 Wyeth LLC Antineoplastic combinations containing hki-272 and vinorelbine
EP2326329B1 (en) 2008-08-04 2017-01-11 Wyeth LLC Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
US8623592B2 (en) 2008-08-15 2014-01-07 Merrimack Pharmaceuticals, Inc. Methods and systems for predicting response of cells to a therapeutic agent
DK3000467T3 (da) 2009-04-06 2023-03-27 Wyeth Llc Behandling med neratinib mod brystkræft
TWI546537B (zh) * 2009-05-19 2016-08-21 維維亞生技公司 提供針對血液腫瘤之體外個人化藥物測試之方法
EP2719708B1 (en) * 2009-11-13 2017-10-25 Daiichi Sankyo Europe GmbH Material and methods for treating or preventing HER-3 associated diseases
JP2013510564A (ja) 2009-11-13 2013-03-28 パンガエア ビオテック、ソシエダッド、リミターダ 肺癌におけるチロシンキナーゼ阻害剤に対する応答を予測するための分子バイオマーカー
EA201201186A1 (ru) 2010-03-11 2013-11-29 Мерримак Фармасьютикалс, Инк. ИСПОЛЬЗОВАНИЕ ErbB3 ИНГИБИТОРОВ В ЛЕЧЕНИИ ТРИЖДЫ НЕГАТИВНОГО И БАЗАЛЬНО-ПОДОБНОГО ВИДОВ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ
EP2447378B1 (en) * 2010-10-29 2017-06-21 ARKRAY, Inc. Probe for detection of polymorphism in EGFR gene, amplification primer, and use thereof
WO2012065071A2 (en) * 2010-11-12 2012-05-18 The Broad Institute Of Mit And Harvard Methods of predicting response to egfr antibody therapy
EP2468883A1 (en) 2010-12-22 2012-06-27 Pangaea Biotech S.L. Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancer
EP2492688A1 (en) 2011-02-23 2012-08-29 Pangaea Biotech, S.A. Molecular biomarkers for predicting response to antitumor treatment in lung cancer
CN107419018B (zh) * 2012-02-16 2020-09-04 江苏宏微特斯医药科技有限公司 一种基于Blocker引物和ARMS引物检测基因突变的方法和试剂盒
WO2013190089A1 (en) 2012-06-21 2013-12-27 Pangaea Biotech, S.L. Molecular biomarkers for predicting outcome in lung cancer
US9873913B2 (en) * 2013-03-08 2018-01-23 Roche Molecular Systems, Inc. Mutation testing
EP3087394A2 (en) 2013-12-27 2016-11-02 Merrimack Pharmaceuticals, Inc. Biomarker profiles for predicting outcomes of cancer therapy with erbb3 inhibitors and/or chemotherapies
WO2016055380A1 (en) * 2014-10-09 2016-04-14 Roche Diagnostics Gmbh Mutations in the epidermal growth factor receptor kinase domain
GB201507202D0 (en) * 2015-04-28 2015-06-10 Stfc Science & Technology Receptor tyosine kinase biomarkers
US10184006B2 (en) 2015-06-04 2019-01-22 Merrimack Pharmaceuticals, Inc. Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors
EP3568132A4 (en) * 2017-01-10 2020-09-09 Wang, Wei MODULATION BY LASOFOXIFEN OF EESTROGENIC SIGNALS OF MEMBRANARY ORIGIN AND METHODS FOR THE TREATMENT OF TUMORS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403953D0 (sv) * 1994-07-15 1994-11-16 Pharmacia Biotech Ab Sequence-based diagnosis
US6759217B2 (en) * 1996-03-26 2004-07-06 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
GB9812768D0 (en) * 1998-06-13 1998-08-12 Zeneca Ltd Methods
KR20070048645A (ko) * 2004-03-01 2007-05-09 더 유니버시티 오브 시카고 상피 성장 인자 수용체 유전자 프로모터에 있어서의 다형성
CN104480200B (zh) * 2004-03-31 2017-12-29 综合医院公司 测定癌症对表皮生长因子受体靶向性治疗反应性的方法
EP1766068A4 (en) * 2004-06-04 2010-03-03 Genentech Inc EGFR Mutations
GB2424886A (en) * 2005-04-04 2006-10-11 Dxs Ltd Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations
US20060223178A1 (en) * 2005-04-05 2006-10-05 Tom Barber Devices and methods for magnetic enrichment of cells and other particles

Also Published As

Publication number Publication date
AU2005337051A1 (en) 2007-04-12
CA2624613A1 (en) 2007-04-12
JP2009511008A (ja) 2009-03-19
IL189705A0 (en) 2008-06-05
WO2007039705A1 (en) 2007-04-12
KR20080028857A (ko) 2008-04-01
ZA200802854B (en) 2009-06-24
CN101351563A (zh) 2009-01-21
NZ566387A (en) 2010-05-28
EP1931798A1 (en) 2008-06-18
BRPI0520530A2 (pt) 2009-09-29
NO20081198L (no) 2008-06-30
US20080286785A1 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
TW200714716A (en) Method
PL1883474T3 (pl) System do zintegrowanej i zautomatyzowanej analizy dna lub białka oraz sposób działania takiego systemu
IL210065A0 (en) Improved method and system for detecting and/or predicting biological anomalies, such as cerebral disorders
EP1746158A4 (en) MICROREACTOR FOR TESTING, GENETIC TEST EQUIPMENT AND GENETIC TEST PROCEDURE
WO2005111212A3 (en) Biological bar code
GB2455204B (en) Devices, systems and methods for the collection, stimulation, stabilization and analysis of a biological sample
HK1134342A1 (en) Assay apparatuses, methods and reagents
MX2010004374A (es) Armazones proteinicos.
WO2008005321A3 (en) Systems and methods for real-time pcr
WO2007044695A3 (en) ANTIBODIES AGAINST SARS-CoV AND METHODS OF USE THEREOF
EP1739402A4 (en) METHODS OF SEPARATING, IDENTIFYING AND ADMINISTERING SPECIMEN AND CORRESPONDING DEVICE, AND METHOD OF ANALYZING DEVICE
EP1782278A4 (en) SYSTEM AND METHOD FOR DOCUMENT ANALYSIS, PROCESSING AND INFORMATION EXTRACTION
EP1869629A4 (en) SYSTEM AND METHOD FOR OFFERING TRAVEL SERVICES
EP1957675A4 (en) SYSTEMS AND METHODS FOR THE BIOMETRIC ANALYSIS OF INDEX FOUNDRING POPULATIONS
WO2007028110A3 (en) Methods for using and identifying modulators of delta-like 4
EP2657705A3 (en) Biomarkers for prostate cancer and methods using the same
EP1869602A4 (en) NEW PROCESSES AND SYSTEMS FOR RECORDING SAMPLE PREPARATIONS
EP1783483A4 (en) X-RAY FLUORESCENCE ANALYSIS PROCESS AND SYSTEM
GB0619833D0 (en) Apparatus for identification,authorisation and/or notification
DE602005013545D1 (de) Vorrichtung zur Sitzbelegungserkennung
WO2007141280A3 (en) Proteins
EP1873533A4 (en) TEST CHIP FOR SAMPLE ANALYSIS AND MICRO ANALYSIS SYSTEM
WO2006060393A3 (en) Biological systems analysis
WO2007010110A3 (fr) Procede de detection des fpca utilisant un agent d'agregation des fpca et un agent de capture des agregats formes
WO2009082445A3 (en) Novel devices for the detection of the presence and/or activity of proteases in biological samples